ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

9,718Medicare Part D Prescriptions Filled, Including Refills
$724K Total Retail Price of All Prescriptions
282 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
OMEPRAZOLE 418 174
LISINOPRIL 298 160
LEVOTHYROXINE SODIUM 241 81
SIMVASTATIN 234 132
TRAMADOL HCL 216 137
LOVASTATIN 212 102
FUROSEMIDE 198 104
METFORMIN HCL 190 52
CITALOPRAM HBR 173 101
HYDROCODONE-ACETAMINOPHEN 173 105 S3
METOPROLOL TARTRATE 159 63
ZOLPIDEM TARTRATE 152 97
POTASSIUM CHLORIDE 132 71
OXYCODONE HCL-ACETAMINOPHEN 119 61 S2
ATENOLOL 115 86
FLUTICASONE PROPIONATE 113 29
ALENDRONATE SODIUM 111 47
ADVAIR DISKUS 111 68
SINGULAIR 103 36
AMLODIPINE BESYLATE 90 82
RISPERIDONE 89 18
DONEPEZIL HCL 86 37
ATORVASTATIN CALCIUM 85 43
CARBAMAZEPINE 84 29
AZITHROMYCIN 84 47
SPIRIVA 83 70
DIVALPROEX SODIUM 83 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 55
BUSPIRONE HCL 83 12
GEMFIBROZIL 82 22
PROAIR HFA 80 63
SERTRALINE HCL 79 45
RANITIDINE HCL 78 40
ROPINIROLE HCL 75 47
TAMSULOSIN HCL 74 31
FENTANYL 73 42 S2
WARFARIN SODIUM 70 18
ZETIA 70 30
HYDROCHLOROTHIAZIDE 69 35
PREDNISONE 68 0
NYSTATIN 62 16
CIPROFLOXACIN HCL 62 23
GABAPENTIN 61 48
ACTONEL 61 0
QUETIAPINE FUMARATE 61 17
PHENYTOIN SODIUM EXTENDED 60 23
OXYCODONE-ACETAMINOPHEN 60 46 S2
NAMENDA 56 0
TRILIPIX 56 29
POLYETHYLENE GLYCOL 3350 56 28
LEVETIRACETAM 55 14
MONTELUKAST SODIUM 54 23
NAPROXEN 54 12
PRAVASTATIN SODIUM 52 24
MELOXICAM 52 28
IBUPROFEN 51 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.